6EK-98555-77003
2 vaccinations
1 coded response
6 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 440 / OH
- Registered
- 2021-12-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-06
Dose 1 — Janssen/Johnson & Johnson
-
2021-12-07
Dose 2 — Pfizer-BioNTech
-
2021-12-08
Registered in v-safe
- 2021-12-08
- 2021-12-10
- 2021-12-11
- 2021-12-12
-
2022-01-06
Survey response — day 28, dose 2MedDRA: Eye pruritus, Lacrimation increased, Nasal congestion, Nasal pruritus, Oropharyngeal pain, Pain, Rhinorrhoea, SARS-CoV-2 test — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Runny stuffy itchy nose, runny itchy eyes, sore throat, upper body aches (not bad) Just got a covid test done yesterdayMedDRA releases: 2024-11 · check-in free text available
- 2022-01-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-06 | Janssen/Johnson & Johnson | No |
| 2 | 2021-12-07 | Pfizer-BioNTech | No |
Free text
Release 10 — day 28, dose 2
Symptoms: Runny stuffy itchy nose, runny itchy eyes, sore throat, upper body aches (not bad) Just got a covid test done yesterday
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Eye pruritus | · | · | ✓ |
| SD | Lacrimation increased | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasal pruritus | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release